返回
學術, 藥物, 阿茲海默症, ApoE4
Neurologist Dr. Lawrence Wong recommends that ApoE4 gene testing be performed before starting new Alzheimer's drug treatment to assess the risk of brain edema/brain microbleeding [Reprinted from Sing Tao.com]
Early symptoms of Alzheimer's disease can be easily confused with aging dementia. Doctors recommend that those who suspect symptoms should seek early consultation and treatment. New drugs can delay the disease and are suitable for early patients. Alzheimer's disease is caused by the accumulation of plaques in the brain. As the disease worsens, patients gradually lose their living functions. Non-drug treatments include cognitive training. Traditional drugs target symptoms, and new drugs in recent years can remove plaques and delay the disease. ApoE4 gene testing is recommended before treatment to assess risks and ensure safety. Studies have shown that 81% of patients can recover within 4 months.
For more details, please refer to the SingTao.com report: https://shorturl.at/2lR97
Related articles:
APOE gene testing opens the door to future Alzheimer's disease treatment